Marine natural products as anticancer agents 2.0

Alves, Celso; Diederich, Marc

http://hdl.handle.net/10400.8/8758

Utilize este identificador para referenciar este registo.

Nome:	Descrição:	Tamanho:	Formato:
Alves et al_2023_marinedrugs-21-00247.pdf		201.25 KB	Adobe PDF	Ver/Abrir

Contacte-nos

Autores

Alves, Celso

Diederich, Marc

Resumo(s)

[Introduction] Global cancer incidence and death are expected to increase to 28.4 million cases by 2040, despite efforts to understand cancer biology better and to improve its diagnosis and therapy [1]. Inappropriate therapeutic regimens and tumor recurrence due to the development of drug resistance are two major clinical challenges impacting poor patient outcomes [2]. Over the last few decades, the marine environment has become an important source of molecules with potent anticancer properties, exhibiting unusual chemical features and mechanisms of action. Twelve of seventeen drugs of marine origin approved by regulatory entities are used against cancer, and thirty-four of forty compounds in the marine pharmaceuticals pipeline indicate “cancer therapy” [3].